Trials / Completed
CompletedNCT02289612
Glycemic and Satiety Response Study of Fibre-Enriched Pudding Products
The Pudding Study: The Effect of Effect of Fibre-enriched Pudding Products on Glycemic and Satiety Response in Adults at Risk for Type 2 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- University of Guelph · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the specific properties of a variety of dietary fibres that lead to different postprandial glycemic and satiety responses in individuals at risk for type 2 diabetes. This is accomplished by utilizing a variety of dietary fibres that demonstrate a wide range of properties in a pudding product, and by examining the ability of each of these to limit gastric emptying, limit glucose absorption, limit insulin secretion, and improve satiety, versus a low fibre control product.
Detailed description
The purpose of this study is to determine the specific properties of a variety of dietary fibres that lead to different postprandial glycemic and satiety responses in individuals at risk for type 2 diabetes. This is accomplished by utilizing a variety of dietary fibres that demonstrate a wide range of properties in a pudding product, and by examining the ability of each of these to limit gastric emptying, limit glucose absorption, limit insulin secretion, and improve satiety, versus a low fibre control product. To accomplish this, a randomized, double-blinded, placebo controlled, crossover study design will be used, in order to determine the different effects of a variety of fibre-enriched pudding products on markers of type 2 diabetes and satiety response, versus low-fibre control puddings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Yellow Mustard Gum Fibre | |
| OTHER | Soluble Flaxseed Gum Fibre | |
| OTHER | Fenugreek Gum Fibre |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2014-11-13
- Last updated
- 2018-05-08
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02289612. Inclusion in this directory is not an endorsement.